Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Featured
Page 122
Featured
Featured posts
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
BridgeBio’s BEYONTTRA approved by European Commission to treat ATTR-CM
UK unveils funding for AI companies to transform cancer care and spark new drug breakthroughs
Novartis’ Kymriah receives EC approval as first CAR-T cell therapy for...
5th May 2022
Hikma completes acquisition of Custopharm
5th May 2022
API partners with University of Saskatchewan scientist to discover and develop...
5th May 2022
ACG appoints Udit K Singh as CEO of ACG Inspection
28th April 2022
New University of Birmingham spinout to speed development for ocular disease...
28th April 2022
Pfizer and Biohaven’s VYDURA (Rimegepant) granted first ever marketing authorization by...
28th April 2022
Steve Morgan Foundation donates £50m to cure type 1 diabetes
28th April 2022
Sygnature Discovery acquires Peak Proteins, to strengthen its drug discovery capabilities
26th April 2022
New £1.2 million funding to advance development of investigational MND drug
25th April 2022
Mundipharma and Cidara Therapeutics announce first presentation of results from global...
25th April 2022
1
...
121
122
123
...
146
Page 122 of 146
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...